Germacrone promotes diabetic ulcer healing via Hedgehog pathway activation
International Immunopharmacology · 2026-10 · 186 · 117100
DOI: 10.1016/j.intimp.2026.117100 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-10. Verfasst von Yun-Xi Cai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medici…. Hauptthemen laut MEDLINE: Hedgehog Proteins, Wound Healing, Diabetes Mellitus, Experimental, Sesquiterpenes, Germacrane. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Shanghai Municipal Health Commission, State Administration of Traditional Chinese Medicine of the People's Republic of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND Diabetic ulcers (DUs) are characterized by delayed repair, persistent inflammation, and impaired angiogenesis, and effective topical treatments remain limited. PURPOSE To investigate the therapeutic effects and mechanisms of Germacrone in DU healing. METHODS Network pharmacology and molecular docking were utilized to predict therapeutic targets. In vitro assays evaluated Germacrone's biological effects and pathway dependence. The effects of Germacrone on diabetic wound healing were assessed in a streptozotocin (STZ)-induced diabetic mouse model. RESULTS Network pharmacology analysis identified angiogenesis-related Hedgehog signaling as a potential pathway mediating the effects of Germacrone in DUs. Molecular docking showed favorable binding between Germacrone and the Hedgehog-related regulatory molecule GSK3B, with a predicted binding energy of -7.3 kcal/mol, and CETSA further supported intracellular target engagement between Germacrone and GSK3B. In vitro experiments showed that Germacrone suppressed GSK3B kinase activity, as indicated by increased inhibitory phosphorylation of GSK3B at Ser9 and reduced phosphorylation of β-catenin. Moreover, Germacrone promoted HUVEC proliferation, reduced IL-1β and IL-6 mRNA expression, increased Hedgehog-related protein expression, and enhanced HUVEC migration and tube formation. Importantly, Hedgehog pathway inhibition with GANT61 attenuated the promotive effects of Germacrone on HUVEC migration and tube formation, suggesting dependence on Hedgehog signaling. In STZ-induced diabetic mice, Germacrone markedly accelerated wound closure, enhanced Hedgehog signaling and angiogenesis, suppressed inflammatory activation, and improved re-epithelialization. CONCLUSION Germacrone effectively promotes DU healing by activating the Hedgehog signaling pathway, enhancing angiogenesis, and reducing inflammation. This study highlights Germacrone as a promising therapeutic candidate for DUs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China; Institute of Dermatology, Yueyang Hospital…
- Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao 266071, China.
- Shanghai Skin Disease Hospital, Institute of Dermatology, School of Medicine, Tongji University, Shanghai 200443, China.
- Institute of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China; Shanghai Skin Disease Hospital, Institute o…
- Shanghai Skin Disease Hospital, Institute of Dermatology, School of Medicine, Tongji University, Shanghai 200443, China. Electronic address: 18336328473@163.com.
Förderung
- Shanghai Municipal Health Commission
- State Administration of Traditional Chinese Medicine of the People's Republic of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Cai, Y. X., Liu, Q. K., Huang, Q. Y., Kuai, L., Luo, Y., Song, J. K., Zhang, Y., Xu, H. T., Wang, R. P., Ru, Y., Yang, D., Li, B., Ma, X. X., & Zhang, Z. (2026). Germacrone promotes diabetic ulcer healing via Hedgehog pathway activation. International Immunopharmacology, 186, 117100. https://doi.org/10.1016/j.intimp.2026.117100
Vancouver
Cai YX, Liu QK, Huang QY, Kuai L, Luo Y, Song JK, et al. Germacrone promotes diabetic ulcer healing via Hedgehog pathway activation. International Immunopharmacology. 2026;186:117100. doi:10.1016/j.intimp.2026.117100
BibTeX
@article{Cai2026,
author = {Cai, Yun-Xi and Liu, Qing-Kai and Huang, Qiu-Yang and Kuai, Le and Luo, Ying and Song, Jian-Kun and Zhang, Ying and Xu, Hao-Tian and Wang, Rui-Ping and Ru, Yi and Yang, Dan and Li, Bin and Ma, Xiao-Xuan and Zhang, Zhan},
title = {Germacrone promotes diabetic ulcer healing via Hedgehog pathway activation},
journal = {International Immunopharmacology},
year = {2026},
volume = {186},
pages = {117100},
doi = {10.1016/j.intimp.2026.117100}
}
EUVIMED